Title:Current Strategies and Drug Targets in the Management of Type 2 Diabetes Mellitus
Volume: 19
Issue: 15
Author(s): Paranjeet Kaur, Amit Mittal, Surendra Kumar Nayak, Manish Vyas, Vijay Mishra and Gopal L. Khatik*
Affiliation:
- Department of Pharmaceutical Chemistry, School of Pharmaceutical Sciences, Lovely Professional University, Jalandhar-Delhi G.T. Road, Phagwara (Punjab) 144411,India
Keywords:
Diabetes, antidiabetic agents, hypoglycemia, hypoglycemic drugs, PPAR agonists, mellitus.
Abstract: Background: Diabetes is one of the major concerns worldwide which leads to increased
level of blood glucose due to deficiency of insulin and the development of insulin resistance in diabetic
individuals. Basically, its impact arises due to rapid urbanization, improper diet intake, and increasingly
inactive lifestyle. Diabetic patients develop serious complications with the development of disease
at later stages, such as obesity, the risk of stroke and heart failure. Globally, an estimated 422
million adults are living with type 2 diabetes mellitus.
Methods: We searched the scientific database using relevant keywords. Among the searched literature,
only peer-reviewed papers were collected which addresses our questions. The retrieved quality
papers were screened and analyzed critically. The key findings of these studies are included along
with the importance.
Results: The quality research paper included in the review, particularly the antidiabetic drugs which
account for the second largest market by sales in the pharmaceutical industry after cancer. So the research
came up with several novel therapeutic targets for the management of type 2 diabetes, to produce
newer generation antidiabetic drug by offering a new concept for developing new drug candidates.
Conclusion: This review discusses the strategies and future perspectives in the management of type 2
diabetes mellitus particularly antidiabetic agents which are helpful for the betterment of diabetic patients.
